Synbiotic Dietary Supplement and Gut Microbiota
NCT04097106 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2024-12-09
Summary
To test the feasibility and safety of our designer synbiotic on gastrointestinal symptoms and gut microbiota and fecal metabolomics.
Conditions
- Healthy
Interventions
- DIETARY_SUPPLEMENT
-
Synbiotic
Synbiotic dietary supplement in capsule form
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Principal Investigators
-
Gail Cresci · The Cleveland Clinic
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-11-10
- Primary Completion
- 2022-06-27
- Completion
- 2022-06-27
Countries
- United States
Study Locations
More Related Trials
-
Next-Generation Synbiotic in Individuals With Overweight or Obesity
NCT06213480 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluating the Effects of a Synbiotic Versus Probiotic or Placebo on Gut Microbiota and Cardiometabolic Health: A Randomized Double-Blind Placebo Controlled Trial
NCT06544915 ·Status: RECRUITING ·Phase: NA
-
A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial Overgrowth
NCT07215676 ·Status: COMPLETED ·Phase: NA
-
Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome
NCT03201068 ·Status: COMPLETED ·Phase: NA
-
Effects of Synbiotics on Obesity
NCT06578143 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Can Synbiotic Use Effect Gut Bacteria and the Immune Response in Older People
NCT01226212 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection
NCT04581018 ·Status: UNKNOWN ·Phase: NA
-
Effects of Probiotics on Metabolic Syndrome ,Intestinal Microflora and SCFA.
NCT06183801 ·Status: COMPLETED ·Phase: NA
-
Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects
NCT02151825 ·Status: COMPLETED ·Phase: NA
-
Multiomic Signatures of Microbial Metabolites Following Prebiotic Fiber Supplementation
NCT03925597 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection
NCT04420676 ·Status: COMPLETED ·Phase: NA
-
The Effect of Prebiotic Synergy1 Supplementation on Microbiota, Protein Metabolism and Gastrointestinal (GI) Symptoms in People Consuming High Protein Diet
NCT02827760 ·Status: COMPLETED ·Phase: NA
-
Effect of a Synbiotic Supplement on a High-protein Diet
NCT03123510 ·Status: UNKNOWN ·Phase: NA
-
Effects of a Synbiotic Supplement on Metabolic & Cognitive Outcomes Among Older Adults
NCT06845995 ·Status: COMPLETED ·Phase: NA
-
Research on the Role of Probiotics in Human Intestinal Health
NCT06886711 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of MYCOBIOTIC® in Children and Adults With Abdominal Symptoms.
NCT04909437 ·Status: COMPLETED ·Phase: NA
-
Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health
NCT02867605 ·Status: COMPLETED ·Phase: NA
-
The Symbiont-Restore Study
NCT05942586 ·Status: COMPLETED ·Phase: NA
-
Gut Flora Dependent Metabolism of Dietary Phosphatidylcholine and Cardiovascular Disease
NCT01519310 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy Adults
NCT05595980 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Synbiotic Formula in Patient With COVID-19
NCT04730284 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Synbiotics on the Upper Respiratory Tract Infection
NCT04960878 ·Status: COMPLETED ·Phase: NA
-
Ritual Synbiotic+, a Dietary Supplement Designed to Impact Gastrointestinal Health, Mood, and Behavior in Women
NCT06834984 ·Status: RECRUITING ·Phase: NA
-
Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile
NCT02127814 ·Status: COMPLETED ·Phase: NA
-
Probiotics in Preventing Antibiotic Associated Diarrhoea Including Clostridium Difficile Infection
NCT01087892 ·Status: COMPLETED ·Phase: NA